Building on this method, Genetix has developed a technology that traps, detects and measures the relative secretion of monoclonal antibody from the hybridomas (or transfected cells such as myelomas).

This includes investigator proteins of interest and monoclonal antibodies from existing hybridoma cell lines. Molecular Characterization of purified proteins by various biophysical methods. Core ...

Regardless of whether individuals are screening CHO cells, hybridoma populations, whole B cell repertoires, or other cell types, methods like clone picking, cell sorting¸ or limiting dilutions ...

This article explores the pivotal role of recombinant antibody technology in the biopharmaceutical industry, highlighting its ...

Scientists have developed numerous monoclonal antibody (mAb)-based therapies for the treatment of ailments, such as cancer, ...

View full profile. Learn about our editorial policies. “All of the methodology that existed before flow cytometry suddenly could be applied to the single cell,” said Thomas Jovin, a biophysicist at ...

Since the first mAb approval in 1986, advancements like refining hybridoma technology and the advent of phage display have significantly improved mAb efficacy and streamlined cell line development and ...

Here’s how it works. It feels like the Splinter Cell remake has been on its way for a decent while now, which isn't helped by the fact it's been over two years since we heard anything official ...

cell and tissue culture technologies, metabolic engineering, biomaterials, hybridoma technology, and separation technologies. With the advent of improved techniques for acquiring large-scale ...

Cells are the smallest unit of life and the building blocks for all organisms. Each component of a cell has its own function. Animal and plant cells differ and they have similarities. Nucleus ...

Cell Line Development MarketThe Cell Line Development Market is experiencing a significant upsurge, driven by advancements in biopharmaceutical research. According to a recent market analysis, the ...